OPEN END TURBO PUT WARRANT - BB BIOTECH N Share Price

Certificat

VBIO5U

CH1338975761

Market Closed - Swiss Exchange 16:20:00 21/06/2024 BST
0.2 CHF -4.76% Intraday chart for OPEN END TURBO PUT WARRANT - BB BIOTECH N
1 month+42.86%
Date Price Change
21/06/24 0.2 -4.76%
19/06/24 0.21 +5.00%
18/06/24 0.2 +5.26%
17/06/24 0.19 +11.76%
12/06/24 0.17 -5.56%

Delayed Quote Swiss Exchange

Last update June 21, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying BB BIOTECH AG
Issuer UBS
VBIO5U
ISINCH1338975761
Date issued 19/04/2024
Strike 44.64 CHF
Maturity Unlimited
Parity 30.03 : 1
Emission price 0.19 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 0.21 CHF
Lowest since issue 0.09 CHF
Spread 0.01 CHF
Spread %5.00%

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
38.8 CHF
Average target price
47.7 CHF
Spread / Average Target
+22.94%
Consensus
  1. Stock Market
  2. Certificates
  3. VBIO5U Certificat